XML 109 R61.htm IDEA: XBRL DOCUMENT v3.19.1
Shareholders’ Equity - Share capital (Details)
1 Months Ended 12 Months Ended
Jun. 28, 2017
EUR (€)
Nov. 30, 2018
USD ($)
$ / shares
shares
Sep. 30, 2018
EUR (€)
Nov. 30, 2017
EUR (€)
Dec. 31, 2018
EUR (€)
shares
Dec. 31, 2017
EUR (€)
shares
Dec. 31, 2016
shares
Dec. 31, 2018
$ / shares
Dec. 31, 2018
EUR (€)
shares
Nov. 30, 2018
€ / shares
Nov. 07, 2018
USD ($)
Sep. 30, 2018
$ / shares
shares
Nov. 30, 2017
$ / shares
shares
Nov. 30, 2017
€ / shares
shares
Jun. 28, 2017
$ / shares
shares
Jun. 28, 2017
€ / shares
shares
Dec. 31, 2015
shares
Shareholders’ Equity                                  
Authorized share capital | €                 € 7,200,000                
Maximum aggregate offering of ordinary shares | $                     $ 300,000,000            
Par value per share | $ / shares               $ 0.04                  
Shares were issued and fully paid in cash                 43,149,987                
Treasury shares           4,503,149     4,277,051                
Shares issued in the period | €         € 84,191,000 € 25,685,000                      
Ordinary                                  
Shareholders’ Equity                                  
Number of shares issued           36,425,014 23,346,856   43,149,987               23,345,965
Issued for cash         6,612,500 8,573,975                      
Issued for services         112,473                        
Exercise of share options         226,098 1,034 891                    
Treasury shares issued         (226,098) 4,503,149                      
Number of shares authorised                 90,000,000                
Preferred                                  
Shareholders’ Equity                                  
Number of shares authorised                 90,000,000                
Market offering program                                  
Shareholders’ Equity                                  
Number of shares issued           976,477                      
Transaction cost | €           € 127,000                      
Net proceeds | €           € 4,138,000                      
Institutional investors                                  
Shareholders’ Equity                                  
Number of shares issued                             1,200,000 1,200,000  
Share price | (per share)                             $ 5.00 € 4.40  
Gross proceeds | € € 5,278,000                                
Transaction cost | € 414,000                                
Net proceeds | € € 4,864,000                                
Underwritten public offering and direct offering                                  
Shareholders’ Equity                                  
Number of shares issued                       6,612,500 6,397,498 6,397,498      
Share price | (per share)                       $ 15.75 $ 3.25 € 2.76      
Gross proceeds | €     € 89,983,000 € 17,671,000                          
Transaction cost | €     5,792,000 988,000                          
Net proceeds | €     € 84,191,000 € 16,683,000                          
H.C. Wainwright & Co | Ordinary                                  
Shareholders’ Equity                                  
Maximum aggregate offering of ordinary shares | $                     $ 75,000,000            
Ionis Pharmaceuticals, Inc | Worldwide License Agreement                                  
Shareholders’ Equity                                  
Number of shares issued   112,473                              
Maximum aggregate offering of ordinary shares | $   $ 2,500,000                              
Share price | (per share)   $ 22.23               € 19.46              
Percent of net sales royalties   20.00%